Search - tctmd.com

Displaying 121 - 140 of 314

Sort: Relevancy | Date

News Conference News TCT 2016

Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

硬 CTO 斑块的新软化方法可以降低手术难度

Yael L. Maxwell

November 02, 2016

Presentation TCT 2016

The Right Choice: Endovascular Therapy vs Surgical Bypass for CLI

Presenter: William A. Gray, Mehdi H. Shishehbor, Koen Deloose

November 01, 2016

Presentation TCT 2016

Transradial Access for Subclavian, Innominate, and Carotid Artery Disease

Presenter: William A. Gray, Mehdi H. Shishehbor, Sasko Kedev

November 01, 2016

Presentation TCT 2016

Overview of Subclavian and Innominate Artery Interventions

Presenter: William A. Gray, Mehdi H. Shishehbor, Jacques Busquet

November 01, 2016

Presentation TCT 2016

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Distal Embolic Protection With Contemporary Devices and Techniques Provides Optimal CAS Outcomes

Presenter: Sriram S. Iyer, John R. Laird Jr., William A. Gray

November 01, 2016

Presentation TCT 2016

Are Mesh-Covered Stents the Future of CAS? Evaluation With OCT and IVUS

Presenter: Sriram S. Iyer, John R. Laird Jr., William A. Gray

November 01, 2016

Presentation TCT 2016

Designing a Complication-Free DCB: Is It Possible or Necessary?

Presenter: Koen Deloose, William A. Gray, Juan F. Granada

November 01, 2016

Presentation TCT 2016

DCB in BTK Intervention: Necessary Technical and Clinical Improvements to Unlock" the BTK Application

Presenter: Koen Deloose, William A. Gray, Mahmood K. Razavi

November 01, 2016

Presentation TCT 2016

Editorial Perspective: Given DCB Results, Is There Any Role for Stenting or Atherectomy in SFA Intervention?

Presenter: Koen Deloose, William A. Gray, Lawrence A. Garcia

November 01, 2016

Presentation TCT 2016

Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world"

Presenter: Koen Deloose, William A. Gray

November 01, 2016

Presentation TCT 2016

"DCB Efficacy In the SFA: Class-Effect or Device Specific"

Presenter: Koen Deloose, William A. Gray, Salvatore Cassese

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

Presenter: Koen Deloose, William A. Gray, Prakash Krishnan

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix

Presenter: Koen Deloose, William A. Gray, Kenneth Rosenfield

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA

Presenter: Koen Deloose, William A. Gray, John R. Laird Jr.

November 01, 2016

Presentation TCT 2016

Trial #9 - The Essentials ofIN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloon for Femoropopliteal Lesions

Presenter: William A. Gray, Stephan Windecker, John R. Laird Jr.

October 31, 2016

Presentation TCT 2016

ACT I Critique: Pro and Con

Presenter: William A. Gray, Stephan Windecker, Klaus D. Mathias

October 31, 2016

Presentation TCT 2016

Trial #8 - The Essentials ofThe ACT I Trial: Carotid Stenting vs Surgery In Asymptomatic Patients

Presenter: William A. Gray, Stephan Windecker, Kenneth Rosenfield

October 31, 2016

Presentation TCT 2016

CTSN Severe MR 2-Year Critique: Pro and Con

Presenter: William A. Gray, Stephan Windecker, Patrick M. McCarthy

October 31, 2016

Presentation TCT 2016

Trial #7 - The Essentials ofCTSN SMR Trial - Two-Year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation

Presenter: William A. Gray, Stephan Windecker, Michael Argenziano

October 31, 2016

Advertisement

Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties

硬 CTO 斑块的新软化方法可以降低手术难度

The Right Choice: Endovascular Therapy vs Surgical Bypass for CLI

Transradial Access for Subclavian, Innominate, and Carotid Artery Disease

Overview of Subclavian and Innominate Artery Interventions

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Distal Embolic Protection With Contemporary Devices and Techniques Provides Optimal CAS Outcomes

Are Mesh-Covered Stents the Future of CAS? Evaluation With OCT and IVUS

Designing a Complication-Free DCB: Is It Possible or Necessary?

DCB in BTK Intervention: Necessary Technical and Clinical Improvements to Unlock" the BTK Application

Editorial Perspective: Given DCB Results, Is There Any Role for Stenting or Atherectomy in SFA Intervention?

Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world"

"DCB Efficacy In the SFA: Class-Effect or Device Specific"

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA

Trial #9 - The Essentials ofIN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloon for Femoropopliteal Lesions

ACT I Critique: Pro and Con

Trial #8 - The Essentials ofThe ACT I Trial: Carotid Stenting vs Surgery In Asymptomatic Patients

CTSN Severe MR 2-Year Critique: Pro and Con

Trial #7 - The Essentials ofCTSN SMR Trial - Two-Year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content